In the search for effective treatments across the neurological spectrum, scientists are uncovering powerful clues from unexpected sources—from the regenerative abilities of zebrafish to the metabolic effects of diabetes medications. This week’s research highlights offer a window into emerging strategies that could redefine how we approach healing in the central nervous system.
We explore how certain animals naturally regenerate neurons after injury, offering models that may inspire new directions for spinal cord and brain repair. Meanwhile, advances in digital technology are reshaping clinical trials for Parkinson’s disease, aiming to streamline development and improve outcomes. And in Alzheimer’s research, a drug originally developed for diabetes shows promise in reducing amyloid pathology by energizing microglial cells.
These diverse insights, while still early in their application to humans, point to new possibilities in regeneration, trial design, and the treatment of complex neurodegenerative conditions.
1. Blueprints for healing: central nervous system regeneration in zebrafish and neonatal mice
Clinical trials for Parkinson’s remain challenging, especially for disease-modifying therapies. This review explores how digital tools and AI are reshaping early drug development—improving target discovery, candidate selection, and remote monitoring—while highlighting the hurdles that still limit success in later-stage trials.
2. From past to future: Digital approaches to success of clinical drug trials for Parkinson’s disease
Unlike adult humans, zebrafish and neonatal mice can regenerate neurons and repair spinal cord injuries. This review dives into the cellular signals and immune responses behind their remarkable recovery—and explores what it might take to awaken similar potential in adults.
3. SGLT2 Inhibition by Enavogliflozin Significantly Reduces Aβ Pathology and Restores Cognitive Function via Upregulation of Microglial AMPK Signaling in 5XFAD Mouse Model of Alzheimer’s Disease
Enavogliflozin, a diabetes medication, reduced amyloid plaque buildup and improved memory in Alzheimer’s mice by boosting microglial cleanup activity through AMPK signaling. This study highlights how targeting brain inflammation and energy metabolism could open new paths for treating neurodegeneration.
If you’d like to stay informed of the latest publications and breakthroughs in neuron regeneration, join our email newsletter to the right (or below on mobile). We send out weekly updates with the latest papers and studies, as well as podcast episodes with the people driving Neuroregenerative breakthroughs.
